The Omega-3 Index measures the percentage of EPA and DHA in red blood cell membranes and is a biomarker for long-chain omega-3 fatty acid status. Omega-3s have anti-inflammatory properties, which could theoretically influence allergic immune responses. Some observational studies suggest that higher maternal or early-life omega-3 intake may reduce the risk of allergic diseases like asthma, eczema, or food allergies in children. However, randomized controlled trials have yielded inconsistent results, and the evidence for a causal protective effect remains weak. The Omega-3 Index is not a diagnostic test for allergies; it only reflects fatty acid status. Consumers should not assume that raising their Omega-3 Index will prevent or treat allergies. Genetic predisposition, environmental exposures, and overall diet are far more important. Given the mixed evidence, omega-3 supplements should not be marketed as allergy treatments. Measuring the Omega-3 Index can be useful for general health assessment, but not for allergy diagnosis. Evidence: mixed.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-1af16111395345f86ba2feac